Nourish secures investment from Hg
"Social and community care is some of the most important work in our society, and carers deserve the very best technology to support them in this work. Nourish has a modern product that care providers love, developed in close partnership with the people who use it. Better software allows care workers to spend more time on care and less on admin, helping to deliver better outcomes for the people they support."
|
|
|
Welcome to Hg’s monthly update, designed to keep you updated with news from Hg and our
network of portfolio companies. Follow us on LinkedIn.
|
|
|
|
|
Ryan Meadows, CRO of Lovable tells Hg how the company reached $400 million ARR in 15 months, and why ditching seat-based pricing for consumption took one customer from 200 product managers to 8,500 software builders in two months.
|
|
|
|
|
“It's a 100 metre race to be first in AI in these markets. The starting gun went off two or three seconds ago." Nic Humphries shares his view that Hg's portfolio companies already have a head start with more customers and more proprietary data.
|
|
|
|
|
CINC already had an AI product roadmap in place, but they knew they had to execute faster. With the help of Hg Catalyst, they had a live, clickable demo in weeks, and Cephai shipped from idea to live product in just three months.
|
|
|
|
|
Engineers across Hg's portfolio produce 2.5x the output per head versus a year ago, from tools costing a few thousand dollars per engineer. Hg's Portfolio CTO breaks down why the return isn't even.
|
|
|
LISTENING RECOMMENDATIONS
|
Dive into some of the podcasts that we are listening to
|
|
|
|
|
No Priors:
Rethinking Legacy Data Infrastructure
Listen to this podcast for insights on why historical enterprise data, not just compute and models, is becoming the key differentiator for AI.
|
|
|
|
|
It's a recognition of the momentum across the firm this year: $30 billion raised across our flagship funds, over 1,600 AI projects live across the portfolio, and more than 100 agentic products and features shipped. Read more
|
|
|
|
|
Our latest quarterly update has been released highlighting 8 new platform investments worth over $15 billion in the last twelve months and over 35 AI product launches across the portfolio. Read more
|
|
|
|
|
Atlas combines three decades of proprietary clinical, commercial and market access data from Citeline, Evaluate, MMIT and Panalgo with agentic AI, turning complex biopharma questions into decision-ready outputs in minutes rather than days. Read more
|
|
|
|
|
Visma closed H1 2026 with €1.6bn revenue (+18.8% YoY) and ARR past €3bn for the first time. AI is now embedded across all strategic platforms, E-conomic saves customers up to 67 hours a month, FabricAI cuts invoice costs 75%. Read more
|
|
|
|
|
IFS grew ARR 25% and cloud revenue 24% in H1 2026, with 84% of revenue recurring. The results reflect strong revenue growth, customer expansion, and rising demand for AI-powered solutions that deliver measurable outcomes. Read more
|
|
|
|
